PREVENT Risk Score Accurately IDs People With Coronary Artery Calcium
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 21, 2025 -- The 2023 Predicting Risk of Cardiovascular Disease Events (PREVENT) risk score accurately identifies individuals with coronary artery calcium (CAC), according to a research letter published online May 21 in the Journal of the American Heart Association.
Aaron J. Rhee, M.D., from New York University in New York City, and colleagues queried electronic health records to compare PREVENT risk scores with subclinical coronary atherosclerosis, detected through scoring of CAC deposits on coronary computed tomography angiography.
A total of 6,961 patients had no missing PREVENT inputs. The researchers found that PREVENT risk was <5, 5 to 7.5, 7.5 to 20, and >20 percent in 43.6, 15.8, 34.4, and 6.2 percent, respectively, with median CAC of 0, 0, 19, and 101, for each category. The Spearman correlation was 0.47 between PREVENT and CAC scores. Among those with PREVENT score <5 and 5 to 7.5 percent, 24.6 and 45.4 percent, respectively, had CAC ≥1. PREVENT scores provided good discrimination of CAC ≥1 and >100 (areas under the receiver operating characteristic curve, 0.755 and 0.761, respectively). Risk discrimination of incident myocardial infarction events was significantly improved by adding CAC to PREVENT risk (change in c-statistic, 0.014); the reverse was true but not statistically significant.
"The findings illustrate that PREVENT is accurate in identifying people who may have subclinical risk for cardiovascular disease, meaning blocked arteries before symptoms develop," coauthor Morgan E. Grams, M.D, Ph.D., also from New York University, said in a statement.
One author disclosed ties to Heartflow and Abbott Vascular.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Lipoprotein(a) Levels Tied to Increased Risk of Recurrent Atherosclerotic CVD Events
WEDNESDAY, May 21, 2025 -- Higher lipoprotein(a) levels are associated with continuously increasing risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events...
No-Touch Vein Harvesting Reduces Vein Graft Occlusion at Three Years
MONDAY, May 5, 2025 -- A no-touch vein harvesting technique reduces vein graft occlusion and improves patient outcomes at three-year follow-up among patients undergoing coronary...
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.